Quest Diagnostics (DGX) Operating Expenses (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Operating Expenses data on file, last reported at $2.5 billion in Q1 2026.

• Quarterly Operating Expenses rose 8.24% year-over-year to $2.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.7 billion (up 10.3% YoY) and the FY2025 annual result came in at $9.5 billion, up 11.18% from the prior year.
• Operating Expenses grew to $2.5 billion in Q1 2026 per DGX's latest filing, from $2.4 billion in the prior quarter.
• The five-year high for Operating Expenses was $2.5 billion in Q1 2026, with the low at $2.0 billion in Q3 2023.
• Average Operating Expenses over 5 years is $2.2 billion, with a median of $2.1 billion recorded in 2022.
• Year-over-year, Operating Expenses declined 8.05% in 2023 and gained 13.76% in 2025.
• Quest Diagnostics' Operating Expenses stood at $2.2 billion in 2022, then retreated by 8.05% to $2.0 billion in 2023, then grew by 11.83% to $2.3 billion in 2024, then gained by 7.08% to $2.4 billion in 2025, then advanced by 3.14% to $2.5 billion in 2026.
• Business Quant data shows DGX's Operating Expenses at $2.5 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.4 billion in Q3 2025.